The Search for Prognostic Biomarkers in Patients with Surgically Treated Hepatocellular Carcinoma.
作者信息
Dinc Ece J, Patel Madhukar S, Hoshida Yujin, Singal Amit G
机构信息
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
出版信息
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102599. doi: 10.1016/j.jceh.2025.102599. Epub 2025 May 24.
Abstract
摘要
相似文献
1
The Search for Prognostic Biomarkers in Patients with Surgically Treated Hepatocellular Carcinoma.手术治疗肝细胞癌患者预后生物标志物的探索
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102599. doi: 10.1016/j.jceh.2025.102599. Epub 2025 May 24.
2
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.射频（热）消融术与不干预或其他干预措施治疗肝细胞癌的比较
Cochrane Database Syst Rev. 2013 Dec 19;2013(12):CD003046. doi: 10.1002/14651858.CD003046.pub3.
3
Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature.乙型肝炎病毒核心相关抗原 (HBcrAg) 作为肝细胞癌发展的预后标志物：文献的小型系统性评价。
Rev Med Virol. 2022 Nov;32(6):e2353. doi: 10.1002/rmv.2353. Epub 2022 Apr 20.
4
Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B.甲胎蛋白和/或肝脏超声检查用于慢性乙型肝炎患者肝细胞癌的筛查。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD002799. doi: 10.1002/14651858.CD002799.pub2.
5
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
6
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.早期或极早期肝细胞癌患者的管理：一项网络荟萃分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
7
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
8
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
9
The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.经导管动脉化疗栓塞术（TACE）联合热消融与单纯 TACE 治疗肝细胞癌的疗效比较。
Cochrane Database Syst Rev. 2022 Jan 4;1(1):CD013345. doi: 10.1002/14651858.CD013345.pub2.
10
Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis.免疫检查点抑制剂联合治疗的益处及肿瘤突变负担在肝细胞癌中的预测作用：系统评价和荟萃分析。
Int Immunopharmacol. 2022 Nov;112:109244. doi: 10.1016/j.intimp.2022.109244. Epub 2022 Sep 18.
本文引用的文献
1
Validation of Two Prognostic Gene Scores in Patients Undergoing Liver Resection for Hepatocellular Carcinoma.两种预后基因评分在接受肝细胞癌肝切除术患者中的验证
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102544. doi: 10.1016/j.jceh.2025.102544. Epub 2025 Mar 11.
2
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.下一代抗病毒药物与肥胖流行时代的肝癌预防
Hepatology. 2025 Jan 14. doi: 10.1097/HEP.0000000000001227.
3
Liver cancer in 2021: Global Burden of Disease study.2021年肝癌：全球疾病负担研究
J Hepatol. 2025 May;82(5):851-860. doi: 10.1016/j.jhep.2024.10.031. Epub 2024 Oct 30.
4
Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis.肝硬化患者精准肝细胞癌监测策略的成本效益
EClinicalMedicine. 2024 Aug 13;75:102755. doi: 10.1016/j.eclinm.2024.102755. eCollection 2024 Sep.
5
Recent methodological advances in federated learning for healthcare.医疗保健领域联邦学习的最新方法进展。
Patterns (N Y). 2024 Jun 14;5(6):101006. doi: 10.1016/j.patter.2024.101006.
6
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection.肝切除术后肝细胞癌侵袭性复发的组织学预测因子。
J Hepatol. 2024 Dec;81(6):995-1004. doi: 10.1016/j.jhep.2024.06.018. Epub 2024 Jun 24.
7
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future.肝癌的新辅助和辅助系统治疗：现状与未来。
Hepatol Commun. 2024 Jun 3;8(6). doi: 10.1097/HC9.0000000000000430. eCollection 2024 Jun 1.
8
Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?印度肝细胞癌的肝移植：我们为2040年做好准备了吗？
World J Transplant. 2024 Mar 18;14(1):88833. doi: 10.5500/wjt.v14.i1.88833.
9
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.全球肝细胞癌流行病学趋势：对筛查、预防和治疗的启示。
Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26.
10
Disseminative Recurrence Signature for Hepatocellular Carcinoma From Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病来源的肝细胞癌的播散性复发特征
Gastro Hep Adv. 2023;2(5):681-683. doi: 10.1016/j.gastha.2023.03.021. Epub 2023 Mar 20.
Zotero 插件